Josep Masip1,2. 1. Intensive Care Department, Consorci Sanitari Integral, University of Barcelona, Jacint Verdaguer 90, ES-08970, Sant Joan Despí, Barcelona, Spain. jmasip@ub.edu. 2. Cardiology Department, Hospital Sanitas CIMA, Barcelona, Spain. jmasip@ub.edu.
Abstract
PURPOSE OF REVIEW: To assess the role of noninvasive ventilation (NIV) in acute heart failure (AHF). RECENT FINDINGS: NIV rapidly improves the respiratory distress and reduces the need for intubation and even mortality in patients with acute cardiogenic pulmonary edema (ACPE). Therefore, NIV is indicated as first line therapy in ACPE. NIV may also be considered in some cases of cardiogenic shock after stabilization. CPAP is an easier and cheaper technique that is recommended as first-line therapy, particularly in pre-hospital or low-equipped areas. Noninvasive pressure support ventilation is equally effective in these scenarios, and may be preferable in patients with mild fatigue or significant hypercapnia, including those with associated chronic obstructive pulmonary disease (COPD). High flow nasal cannula is an alternative for patients who need prolonged ventilation or those who show poor tolerance to these techniques. NIV should be used as a first-line therapy in all patients with ACPE and should be considered in stable cardiogenic shock and AHF associated to COPD.
PURPOSE OF REVIEW: To assess the role of noninvasive ventilation (NIV) in acute heart failure (AHF). RECENT FINDINGS: NIV rapidly improves the respiratory distress and reduces the need for intubation and even mortality in patients with acute cardiogenic pulmonary edema (ACPE). Therefore, NIV is indicated as first line therapy in ACPE. NIV may also be considered in some cases of cardiogenic shock after stabilization. CPAP is an easier and cheaper technique that is recommended as first-line therapy, particularly in pre-hospital or low-equipped areas. Noninvasive pressure support ventilation is equally effective in these scenarios, and may be preferable in patients with mild fatigue or significant hypercapnia, including those with associated chronic obstructive pulmonary disease (COPD). High flow nasal cannula is an alternative for patients who need prolonged ventilation or those who show poor tolerance to these techniques. NIV should be used as a first-line therapy in all patients with ACPE and should be considered in stable cardiogenic shock and AHF associated to COPD.
Authors: Arnaud W Thille; Pablo Rodriguez; Belen Cabello; François Lellouche; Laurent Brochard Journal: Intensive Care Med Date: 2006-08-01 Impact factor: 17.440
Authors: Christian Mueller; Michael Christ; Martin Cowie; Louise Cullen; Alan S Maisel; Josep Masip; Oscar Miro; John McMurray; Frank W Peacock; Susanna Price; Salvatore DiSomma; Hector Bueno; Uwe Zeymer; Alexandre Mebazaa Journal: Eur Heart J Acute Cardiovasc Care Date: 2016-09-22
Authors: Alasdair Gray; Steve Goodacre; David E Newby; Moyra Masson; Fiona Sampson; Jon Nicholl Journal: N Engl J Med Date: 2008-07-10 Impact factor: 91.245
Authors: Thomas A Tallman; W Frank Peacock; Charles L Emerman; Margarita Lopatin; Jamie Z Blicker; James Weber; Clyde W Yancy Journal: Acad Emerg Med Date: 2008-04 Impact factor: 3.451